Vice President of CMC
Christopher Ryan is the Vice President of CMC at Orange Grove Bio. He has over a decade of experience managing drug development, quality control, and manufacturing. He has worked on the development, manufacturing, and testing of respiratory, ocular, and gastrointestinal drugs for preclinical and clinical testing. His experience includes treatments for Cystic Fibrosis, Bronchiectasis, COPD, Crohn’s disease, Colitis, wound healing, and oncology supportive care. He has also led the development, regulatory clearance, and commercial manufacturing of medical devices to treat dry mouth and oral and dermal wounds.
While his focus is on product development, Dr. Ryan has served as head of operations, manufacturing, quality control, and quality assurance. Throughout his work, he has authored CMC sections for multiple pre-INDs, INDs, IMPDs, and 510ks. Dr. Ryan has a background in host-pathogen interaction, molecular biology, and biochemistry, focusing on polysaccharide and RNA chemistry. He obtained a BS in Biochemistry from the University of Rochester and a Ph.D. in Microbiology from the University of Buffalo.